News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Virtual Tumor Board case on EGFR-mutant NSCLC – IASLC
IASLC/X
Feb 13, 2025, 09:43

Virtual Tumor Board case on EGFR-mutant NSCLC – IASLC

IASLC shared a post on X:

“New Podcast Episode!  

Host Stephen V Liu, moderates a Virtual Tumor Board case on EGFR-mutant NSCLC and acquired resistance to osimertinib.

 Expert insights on treatment strategies & next steps!

Listen now.”

Learn about more episodes on OncoDaily.

cancer EGFR-mutant NSCLC fight against cancer Global awareness Global fight against cancer IASLC NSCLC OncoDaily Oncology osimertinib Stephen V Liu Virtual Tumor Board
Special Coverage
Blog
May 21, 2025, 21:13
2025 Chinese Congress on Holistic Integrative Oncology (CCHIO)
Insight
May 21, 2025, 19:15
Haydeé Verduzco-Aguirre shared study on 20-year breast cancer trends and treatment gaps in São Paulo
Insight
May 21, 2025, 19:10
Samuel Hume: Top 5 advances in medicine this week
Insight
May 21, 2025, 19:04
FDA and HHS announced next steps in Operation Stork Speed for infant formula nutrition standards
Insight
May 21, 2025, 18:49
Joe Y. Chang on upcoming PTCOG 63: IMRT vs IMPT Phase III trials
Blog
May 21, 2025, 18:11
Poland’s Cancer Landscape at Cancer Mission Fair - European Cancer Organisation
Insight
May 21, 2025, 18:05
Goutham Sunny on KRAS G12C inhibition in non-small cell lung cancer
Blog
May 21, 2025, 18:02
Tackling Information Overload in Cancer Research - Train at NCI
Societies
May 21, 2025, 17:54
Patrick Hwu: Kicked off the 2025 Scientific Symposium at Moffitt Cancer Center
Blog
May 21, 2025, 17:54
Applications are Open for the Basic Principles in Oncology Course - European School of Oncology
Career
May 21, 2025, 17:46
Sharon Kapambwe Has Been Appointed as Technical Officer for Cancer Control at WHO Uzbekistan
Opinion
May 21, 2025, 17:41
Bishal Gyawali addressed G7 cancer drug approval claims about Canada with the Lancet Oncology Study